Insider · CIK 0001635930
Powell Scott
cooofficer
Files at WFC (WELLS FARGO & COMPANY/MN). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 9, 2024 | WFC WELLS FARGO & COMPANY/MN | MOption exercise Common Stock, $1 2/3 Par Value | +672 | $0.00 | $0 | 242,714 | Dec 11, 2024 |
| Dec 9, 2024 | WFC WELLS FARGO & COMPANY/MN | FTax withholding Common Stock, $1 2/3 Par Value | -672 | $72.62 | $49k | 242,042 | Dec 11, 2024 |
| Dec 9, 2024 | WFC WELLS FARGO & COMPANY/MN | MOption exercise Common Stock, $1 2/3 Par Value | +1,514 | $0.00 | $0 | 243,556 | Dec 11, 2024 |
| Dec 9, 2024 | WFC WELLS FARGO & COMPANY/MN | FTax withholding Common Stock, $1 2/3 Par Value | -1,514 | $72.62 | $110k | 242,042 | Dec 11, 2024 |
| Dec 9, 2024 | WFC WELLS FARGO & COMPANY/MN | MOption exercise Common Stock, $1 2/3 Par Value | +2,362 | $0.00 | $0 | 244,404 | Dec 11, 2024 |
| Dec 9, 2024 | WFC WELLS FARGO & COMPANY/MN | FTax withholding Common Stock, $1 2/3 Par Value | -2,362 | $72.62 | $172k | 242,042 | Dec 11, 2024 |
| Dec 9, 2024 | WFC WELLS FARGO & COMPANY/MN | MOption exercise Restricted Share Rightderivative | -672 | $0.00 | $0 | 20,129 | Dec 11, 2024 |
| Dec 9, 2024 | WFC WELLS FARGO & COMPANY/MN | MOption exercise Restricted Share Rightderivative | -1,514 | $0.00 | $0 | 44,239 | Dec 11, 2024 |
| Dec 9, 2024 | WFC WELLS FARGO & COMPANY/MN | MOption exercise Restricted Share Rightderivative | -2,362 | $0.00 | $0 | 66,898 | Dec 11, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.